EyePoint Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.79 | -$0.11 | -$0.40 |
| Q2 2024 | 2 | -$0.99 | -$0.13 | -$0.50 |
| Q3 2024 | 2 | -$1.07 | -$0.14 | -$0.55 |
| Q4 2024 | 6 | -$0.61 | -$0.36 | -$0.50 |
| Q1 2025 | 3 | -$0.67 | -$0.48 | -$0.57 |
| Q2 2025 | 2 | -$1.16 | -$0.16 | -$0.59 |
| Q3 2025 | 2 | -$1.32 | -$0.18 | -$0.67 |
| Q4 2025 | 2 | -$1.36 | -$0.18 | -$0.69 |
EyePoint Pharmaceuticals, Inc. Earnings Date And Information
EyePoint Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.54 earnings per share for the quarter, missing analysts' consensus estimates of $-0.48 by $0.06. The company had revenue of 10.52 M for the quarter and had revenue of 46.02 M for the year. EyePoint Pharmaceuticals, Inc. has generated $-2 earnings per share over the last year ($-1.82 diluted earnings per share) and currently has a price-to-earnings ratio of -4.51. EyePoint Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based on prior year's report dates.
EyePoint Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.48 | -$0.54 | -0.06 | $10.40 M | $10.52 M |
| 08/08/2024 | Q2 2024 | -$0.58 | $10.63 M | $9.48 M | ||
| 03/30/2024 | Q1 2024 | -$0.55 | $11.68 M | |||
| 12/30/2023 | Q4 2023 | -$0.33 | $14.03 M | |||
| 11/03/2023 | Q3 2023 | -$0.33 | $7.86 M | $15.20 M | ||
| 08/04/2023 | Q2 2023 | -$0.61 | $79.10 M | $9.11 M | ||
| 05/04/2023 | Q1 2023 | -$0.58 | $7.68 M | |||
| 03/10/2023 | Q4 2022 | -$1.72 | $10.53 M | |||
| 11/04/2022 | Q3 2022 | -$0.49 | $10.93 M | $10.01 M | ||
| 08/05/2022 | Q2 2022 | -$0.52 | $10.86 M | $11.57 M | ||
| 05/06/2022 | Q1 2022 | -$0.60 | $9.29 M | |||
| 03/11/2022 | Q4 2021 | -$0.59 | $11.54 M | |||
| 11/05/2021 | Q3 2021 | -$0.58 | $9.88 M | $9.06 M | ||
| 08/06/2021 | Q2 2021 | -$0.35 | $8.71 M | $9.01 M | ||
| 05/05/2021 | Q1 2021 | -$0.53 | -$0.50 | 0.03 | $7.32 M | |
| 03/12/2021 | Q4 2020 | -$1.07 | $7.13 M | |||
| 11/06/2020 | Q3 2020 | -$0.30 | $13.32 M | $15.70 M | ||
| 08/05/2020 | Q2 2020 | -$1.10 | -$1.04 | 0.06 | $3.79 M | $4.12 M |
| 05/08/2020 | Q1 2020 | -$1.14 | $7.49 M | |||
| 03/16/2020 | Q4 2019 | -$0.98 | $8.63 M |
EyePoint Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is EyePoint Pharmaceuticals, Inc.'s earnings date?
EyePoint Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 27th, 2025 based off last year's report dates.
-
How can I listen to EyePoint Pharmaceuticals, Inc.'s earnings conference call?
The conference call for EyePoint Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read EyePoint Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for EyePoint Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does EyePoint Pharmaceuticals, Inc. generate each year?
EyePoint Pharmaceuticals, Inc. (:EYPT) has a recorded annual revenue of $46.02 M.
-
How much profit does EyePoint Pharmaceuticals, Inc. generate each year?
EyePoint Pharmaceuticals, Inc. (:EYPT) has a recorded net income of $46.02 M. EyePoint Pharmaceuticals, Inc. has generated $-1.82 earnings per share over the last four quarters.
-
What is EyePoint Pharmaceuticals, Inc.'s price-to-earnings ratio?
EyePoint Pharmaceuticals, Inc. (:EYPT) has a price-to-earnings ratio of -4.51 and price/earnings-to-growth ratio is 0.38.
